Waves of Pharmaceutical Investors from East Asia

By Editorial Team 19/08/2019
Summary

Amid limited pharmaceutical raw materials, the government received investment plans from producers of East Asia. One of them is a Chinese drug producer Bio-Medical Technology Co Ltd (BGBMT) that plans to build an active raw material factory for medicines and other pharmaceutical products.

BGBMT plans to build a factory in Karawang New Industry City (KNIC) Industrial Estate, Karawang, West Java. The project, which stands on ​​25,000 square meters, would last for ten years. The factory would produce chemicals for cancer drugs, antivirus, and cytotoxic drugs and hormones. BGBMT Chief Executive Officer Yuan Jiandong said the factory serves as a leading supplier for the Indonesian pharmaceutical industry, as well as a means for collaborative research and technology transfer.

Register now and get free access.

If you want to get free access to our Daily Insights and Weekly Digest, please click "Sign up" button below. If you already have an account, please login.

Sign up
Log in
What do subscribers receive?

As a subscriber, you'll receive daily insights, weekly business digests, and quarterly industrial reports.

What kind of pieces will i get?

In-depth reports on assumption and impact analysis, as well as update and trends mapping, written by our credible and experienced analysts.

And, there is something else…

Register now and get free access, click here to register. Feel free to contact us with any additional questions you have.